Journal
NATURE REVIEWS CANCER
Volume 8, Issue 1, Pages 11-23Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc2291
Keywords
-
Categories
Funding
- Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom
- NCI NIH HHS [R01-CA64033] Funding Source: Medline
Ask authors/readers for more resources
Tyrosine kinases are involved in the pathogenesis of most cancers. However, few tyrosine kinases have been shown to have a well-defined pathogenetic role in lymphomas. The anaplastic lymphoma kinase (ALK) is the oncogene of most anaplastic large cell lymphomas (ALCL), driving transformation through many molecular mechanisms. In this Review, we will analyse how translocations or deregulated expression of ALK contribute to oncogenesis and how recent genetic or pharmacological tools, aimed at neutralizing its activity, can represent the basis for the design of powerful combination therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available